Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2026-01-29 @ 8:33 AM
Study NCT ID:
NCT04326920
Status:
COMPLETED
Last Update Posted:
2022-11-16
First Post:
2020-03-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)
Sponsor:
University Hospital, Ghent
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | COVID-19 | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | GM-CSF | View |
| None | Acute Lung Injury | View |
| None | Hypoxia | View |
| None | Acute Respiratory Distress Syndrome | View |
| None | Corona virus | View |
| None | COVID-19 | View |
| None | SARS (Severe Acute Respiratory Syndrome) | View |
| None | Alveolar Macrophage | View |
| None | Acute Hypoxic respiratory failure | View |